BWX Technologies, Inc. $BWXT Stake Lessened by Amova Asset Management Americas Inc.

Amova Asset Management Americas Inc. lessened its holdings in BWX Technologies, Inc. (NYSE:BWXT) by 2.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 271,308 shares of the technology company’s stock after selling 7,878 shares during the period. Amova Asset Management Americas Inc. owned about 0.30% of BWX Technologies worth $50,024,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Creative Financial Designs Inc. ADV grew its position in BWX Technologies by 250.0% during the second quarter. Creative Financial Designs Inc. ADV now owns 175 shares of the technology company’s stock valued at $25,000 after purchasing an additional 125 shares in the last quarter. Global Trust Asset Management LLC purchased a new stake in shares of BWX Technologies during the 3rd quarter worth about $32,000. WFA of San Diego LLC purchased a new stake in shares of BWX Technologies during the 2nd quarter worth about $29,000. Hantz Financial Services Inc. lifted its holdings in shares of BWX Technologies by 861.9% during the 2nd quarter. Hantz Financial Services Inc. now owns 202 shares of the technology company’s stock valued at $29,000 after buying an additional 181 shares during the last quarter. Finally, Quent Capital LLC bought a new stake in shares of BWX Technologies in the 3rd quarter valued at approximately $43,000. 94.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. BNP Paribas Exane started coverage on shares of BWX Technologies in a research report on Thursday, January 15th. They set a “neutral” rating and a $215.00 price objective on the stock. CJS Securities raised BWX Technologies to a “strong-buy” rating in a report on Friday, December 12th. BTIG Research boosted their target price on BWX Technologies from $225.00 to $235.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Zacks Research raised BWX Technologies from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Finally, Wall Street Zen lowered shares of BWX Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Three analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, BWX Technologies has an average rating of “Moderate Buy” and a consensus target price of $200.45.

BWX Technologies Price Performance

Shares of BWXT stock opened at $205.69 on Thursday. The company has a market capitalization of $18.81 billion, a P/E ratio of 57.62, a P/E/G ratio of 3.36 and a beta of 0.83. BWX Technologies, Inc. has a 12 month low of $84.21 and a 12 month high of $220.57. The stock has a 50 day moving average of $200.29 and a two-hundred day moving average of $188.23. The company has a current ratio of 2.32, a quick ratio of 2.25 and a debt-to-equity ratio of 1.64.

BWX Technologies (NYSE:BWXT) last posted its quarterly earnings results on Monday, February 23rd. The technology company reported $1.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.17. BWX Technologies had a net margin of 10.28% and a return on equity of 30.94%. The firm had revenue of $885.84 million for the quarter, compared to the consensus estimate of $837.47 million. During the same quarter in the previous year, the company earned $0.92 earnings per share. The business’s revenue was up 18.7% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.550-4.700 EPS. As a group, equities analysts expect that BWX Technologies, Inc. will post 3.23 EPS for the current year.

BWX Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 27th. Stockholders of record on Wednesday, March 11th will be paid a $0.27 dividend. The ex-dividend date is Wednesday, March 11th. This represents a $1.08 annualized dividend and a dividend yield of 0.5%. This is an increase from BWX Technologies’s previous quarterly dividend of $0.25. BWX Technologies’s dividend payout ratio is currently 28.01%.

Insider Buying and Selling

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $203.26, for a total transaction of $2,032,600.00. Following the completion of the transaction, the chief executive officer directly owned 177,594 shares in the company, valued at $36,097,756.44. This represents a 5.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Gerhard F. Burbach sold 1,983 shares of BWX Technologies stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $208.61, for a total transaction of $413,673.63. The disclosure for this sale is available in the SEC filing. Insiders sold 13,327 shares of company stock worth $2,734,844 in the last 90 days. 0.47% of the stock is owned by company insiders.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.